Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
. Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex
-
Postdoctoral Research Fellow – Cantor Lab Dana-Farber Cancer Institute Boston, MA Full Time The Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute invites applications
-
Details Posted: 24-Apr-24 Location: Boston, Massachusetts Salary: Open Internal Number: 2024-39449 The Dana-Farber Cancer Institute's Department of Data Science is seeking a Director of Training and
-
Postdoctoral Research Fellow – HIV-1 Vaccine Immunology Dana-Farber Cancer Institute Boston, MA Full Time The Reinherz lab at Dana-Farber Cancer Institute and Harvard Medical School is recruiting a
-
Assistant Professor of Immunology - Dana-Farber Cancer Institute & Harvard Medical School Dana-Farber Cancer Institute Boston, MA Full Time – Onsite The Department of Cancer Immunology & Virology
-
in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer
-
apply. Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex
-
the laboratory of Dr. Srinivas Viswanathan at Dana-Farber Cancer Institute (with affiliation to the Broad Institute). We use genomic and cutting-edge genome-scale functional genetic technologies to uncover drivers
-
Research Scientist Dana-Farber Cancer Institute Boston, MA Full Time The Center for Patient Derived Models (CPDM) at DFCI is seeking applicants for the position of Research Scientist I. This is an
-
opportunity to support a cutting edge research laboratory at Harvard Medical School and the Dana-Farber Cancer Institute while carrying out research projects. Dr. David Pellman’s group is studying the mechanism